Michael W. Kahn - Publications

Somatic Stem Cells: Control of Quiescence Versus Activation in Aging and Cancer.

Journal: Cancers

Published: July 20, 2026

Wnt signaling as a regulator of memory T cells: implications for CAR-T cell therapy.

Journal: Frontiers in immunology

Published: March 31, 2026

Myself/God/Nobody: Simple Ways to Begin Discovering the Patient.

Journal: Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry

Published: February 11, 2026

Safely Targeting Cancer, the Wound That Never Heals, Utilizing CBP/Beta-Catenin Antagonists.

Journal: Cancers

Published: March 25, 2025

3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer.

Journal: Cancers

Published: March 28, 2024

Reprogramming of 3D chromatin domains by antagonizing the β-catenin/CBP interaction attenuates insulin signaling in pancreatic cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2023

Targeting Wnt signaling for improved glioma immunotherapy.

Journal: Frontiers in immunology

Published: November 22, 2023

Vertebral osteomyelitis secondary to Streptococcus cristatus infection.

Journal: Heliyon

Published: May 21, 2023

Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation.

Journal: Nature communications

Published: May 14, 2023

Inhibition of Wnt/β-catenin signaling reduces renal fibrosis in murine glycogen storage disease type Ia.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: May 07, 2023

A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I.

Journal: Current molecular pharmacology

Published: April 25, 2023

E7386 is not a Specific CBP/β-Catenin Antagonist.

Journal: Current molecular pharmacology

Published: February 04, 2023